According to the German newspaper Die Welt, the Trump administration offered “large sums of money” to a German biopharmaceutical firm to move its research on a coronavirus vaccine to the USA.
The company, CareVac, a research company based in Tuebingen, is one of a number of companies working on a vaccine to coronavirus. hayamix.com The aim of the move by the Trump administration was to secure exclusive access to the drug when it was ready. Die Welt quoted a German government official saying the offer was to develop the vaccine “only for the United States”.
The move prompted the German government to offer its own financial incentives to keep the company in the country, the report added.
A German Health Ministry later confirmed the report to Reuters.
Full story in The Independent, 16 March 2020